Nevro down on trimming Q2 revenue forecast

Nevro

06/06/2023 16:24

** Nevro Corp's shares  NVRO.O  fall 15.8% to $23.15 
    ** Medical device company cuts its revenue forecast for Q2
to a range of $106 mln to $108 mln from a previous range of $110
mln to $112 mln
    ** NVRO also names Greg Siller as chief commercial officer,
replacing Niamh Pellegrini
     ** Co plans to update its annual outlook when it reports
its Q2 results on Aug. 1
    ** Brokerage firms including Truist Securities and Canaccord
Genuity have lowered PTs on the Nevro stock after the Q2 rev
forecast 
    ** Including session losses, stock lost ~42% YTD 

 (Reporting by Khushi Mandowara in Bengaluru)
 ((Khushi.Mandowara@thomsonreuters.com;))